Skip to content

Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis

Cross-sectional and Prospective Study to Characterize Early-onset Presbycusis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06354010
Acronym
SONG
Enrollment
100
Registered
2024-04-09
Start date
2024-06-14
Completion date
2027-07-01
Last updated
2026-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sensorineural Hearing Loss, Bilateral

Keywords

Adulthood-onset bilateral sensorineural hearing loss, GJB2, Presbycusis, hearing impairement, Deafness, Connexin 26, SONG, Genetic deafness, Adult deafness

Brief summary

The purpose of this study is to characterize and assess the evolution of hearing impairment of patients with adulthood-onset bilateral sensorineural hearing loss carrying mutations on GJB2 gene.

Detailed description

This study aims to characterize patients with adulthood-onset bilateral sensorineural hearing loss not due to any underlying medical condition (likely due to a genetic cause) and to assess the evolution of hearing impairment of those carrying mutations in GJB2 gene. Patients who present with adulthood-onset bilateral sensorineural hearing loss will be screened for the presence of mutation involved in hearing impairment. Patients with GJB2 mutations will be proposed to continue in a follow-up period.

Interventions

GENETICGenotyping

Genotyping to determine if patients present mutations to the gene GJB2.

Audiological assessments

Sponsors

Sensorion
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
30 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

1. Female or Male patients ≥30 and ≤55 years old 2. Bilateral hearing loss first noticed after the age of 16 years old 3. Documented genotyping results showing mutations in GJB2 gene.

Exclusion criteria

1. Deafness with a known, non-genetic cause 2. To the opinion of the investigator, unable and/or unwilling to comply with all the protocol requirements and/or study procedures

Design outcomes

Primary

MeasureTime frameDescription
Evolution of hearing impairment of adult patients with early-onset presbycusis carrying mutations in GJB2 gene.2 yearsEvolution of hearing impairment assessed by Pure Tone Audiometry
Evolution of hearing impairment of adult patients with early-onset presbycusis carrying mutations in GJB2 gene2 yearsEvolution of hearing impairment assessed by Speech in noise

Secondary

MeasureTime frameDescription
Genetic characteristics of adult patients with early-onset presbycusisUnique visitGenotyping
Audiological characteristics of adult patients with early-onset presbycusisUnique visitPure Tone Audiometry
Mood evaluation in adult patients with early-onset presbycusis carrying mutations in GJB2 gene2 yearsMood evaluation assessed with Patient Health Questionnaire for depression (PHQ-9)

Countries

France, United States

Contacts

CONTACTLionel HOVSEPIAN, MD
lionel.hovsepian@sensorion-pharma.com+33786311376
PRINCIPAL_INVESTIGATORMaya ELZIERE, MD

Hôpital Eureopéen Marseille

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 9, 2026